Tara O’Meara serves as Senior Vice President, Development Operations at Hemab. She brings more than 25 years of biotech operations and clinical development experience, especially in rare disease, across small molecules, large molecules, and gene/cell therapy. Prior to Hemab, Tara worked at several growing biotechnology companies where she built the development operations teams and capabilities, including bluebird bio and Relay Therapeutics. Tara has been involved in multiple product approvals throughout her career, including Myozyme®, Skysona™, Zynteglo®, and Abecma®. Tara has a Bachelor of Science in Biology from Tufts University.